Allergan Aesthetics, an AbbVie company , announced the European Commission has approved Boey® (trenibotulinumtoxinE) in Europe, for the temporary improvement in the appearance of moderate to severe ...
Finding a dentist in a city as spread out and fast moving as Washington, DC can feel like a research project on its own.
The FDA accepted the NDA for AXS-12 (reboxetine) for the treatment of cataplexy in narcolepsy, setting a PDUFA target action date of May 1, 2027.
​The UK government has now added warnings about methanol poisoning to its travel advice for 29 destinations, including ...